MedTrace Logo

Cohort of Inflammatory Bowel Disease Patient in Yeouido St. Mary's Hospital

NCT05183256 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2024-07-24

No results posted yet for this study

Summary

Pathologically Inflammatory bowel disease (IBD) is in chronic complex inflammatory gut pathological condition. Although the etiology of IBD is unknown, gut microbiota alteration (dysbiosis) is considered a novel factor involved in the pathogenesis of IBD. The aim of this study is to analyze gut microbiota in IBD patients.

Conditions

  • Inflammatory Bowel Diseases

Sponsors & Collaborators

  • Yeouido St. Mary's Hospital

    lead OTHER

Principal Investigators

  • Ilsoo Kim, MD · Yeouido St. Mary's Hospital

Eligibility

Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-26
Primary Completion
2023-06-30
Completion
2023-07-24

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05183256 on ClinicalTrials.gov